-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Ensysce Biosciences with Buy Rating, Announces Price Target of $2

Benzinga·11/12/2026 12:48:51
Listen to the news
UBS analyst Ashwani Verma initiates coverage on Ensysce Biosciences (NASDAQ:ENSC) with a Buy rating and announces Price Target of $2.